Skip to main content
. 2022 Sep;33(9):1767–1777. doi: 10.1681/ASN.2022020135

Figure 2.

Figure 2.

Prescribed rosuvastatin dose by eGFR category. Rosuvastatin initiators between 2011 and 2019 who had eGFR measurements within 1 year before medication initiation (eGFR ≥60 ml/min per 1.73 m2, n=150,591; eGFR 30–59 ml/min per 1.73 m2, n=24,278; eGFR <30 ml/min per 1.73 m2, n=1504).